TG Therapeutics, Inc. (BIT:1TGTX)
40.00
+0.78 (1.99%)
At close: May 2, 2025
TG Therapeutics Revenue
In the year 2024, TG Therapeutics had annual revenue of $329.00M USD with 40.80% growth. TG Therapeutics had revenue of $108.19M in the quarter ending December 31, 2024, with 146.04% growth.
Revenue
$329.00M
Revenue Growth
+40.80%
P/S Ratio
19.14
Revenue / Employee
$973.38K
Employees
338
Market Cap
6.08B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 329.00M | 95.34M | 40.80% |
Dec 31, 2023 | 233.66M | 230.88M | 8,290.02% |
Dec 31, 2022 | 2.79M | -3.90M | -58.36% |
Dec 31, 2021 | 6.69M | 6.54M | 4,300.66% |
Dec 31, 2020 | 152.00K | - | - |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Intesa Sanpaolo | 25.38B |
UniCredit | 23.99B |
Enel SpA | 75.71B |
Ferrari | 6.68B |
Assicurazioni Generali | 55.30B |
Eni S.p.A. | 90.96B |
Leonardo S.p.a. | 17.76B |
Stellantis | 156.88B |